The Moffitt requests $248,588 in annual direct costs for support of Administration personnel, totaling 2.10 FTE. The budget request represents less than 4% of the total CCSG request and is less than 1% of Moffitt's total Research Administration operational budget. Since all research activities at Moffitt are cancer-related, support of research is in direct support of the Cancer Center Support Grant and is composed of three primary functions: Program Administration, Shared Resource Oversight, and Research Administration. Program administrative support is provided at the division level (Basic Science, Prevention &Control, Translational Science, and Clinical Investigations) with dedicated staff led by a Division Administrator who provides support for the programs and faculty within their division. Shared Resource Oversight occurs through alignment and allocation of functions to specific administrative groups: Laboratory Operations;Clinical Trials Office;Tissue;and Cell Therapies. Research Administration represents a collection of Offices that provide a range of support activities including: Institutional Support Services;Sponsored Research;Grant and Contract Accounting;Research Costs Analysis;Clinical Trials Finance;Protocol Review and Support;and Institutional Regulatory Affairs. The administration of research activities for the Cancer Center is organized under Michael Benedict, PharmD, who reports to Dr. Dalton through the Director of the Moffitt Research Institute (MRI) and Associate Center Director for Cancer Prevention and Control, Dr. Sellers. In addition to reporting to the Director of the MRI, Dr. Benedict has functional responsibilities to all Associate Center Directors. Leadership has changed since the last submission. Dr. Benedict, was recruited back to the Cancer Center to serve as Vice President for Clinical Investigations, and in July 2009, was appointed the sole Vice President for Research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-15
Application #
8495973
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
15
Fiscal Year
2013
Total Cost
$124,599
Indirect Cost
$50,654
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
Rivera, Y M; Moreno, L; Briant, K J et al. (2018) Developing Sustainable Cancer Education Programs: Training Public Health Students to Deliver Cancer 101 in Puerto Rico. J Cancer Educ 33:128-133
Saltos, Andreas; Khalil, Farah; Smith, Michelle et al. (2018) Clinical associations of mucin 1 in human lung cancer and precancerous lesions. Oncotarget 9:35666-35675
Gjyshi, Anxhela; Dash, Sweta; Cen, Ling et al. (2018) Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Sci Rep 8:8291
Maharaj, Kamira; Powers, John J; Achille, Alex et al. (2018) Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Adv 2:3012-3024
Schaal, Courtney M; Bora-Singhal, Namrata; Kumar, Durairaj Mohan et al. (2018) Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer 17:149
Zhu, Genyuan; Brayer, Jason; Padron, Eric et al. (2018) OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms. Cytometry A 93:982-986

Showing the most recent 10 out of 1254 publications